UK markets closed

Addex Therapeutics Ltd (0QNV.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
0.0640-0.1930 (-75.10%)
At close: 05:55PM BST
Currency in CHF

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.87
52-week change 336.49%
S&P500 52-week change 323.76%
52-week high 30.0763
52-week low 30.0000
50-day moving average 30.0628
200-day moving average 30.0628

Share statistics

Avg vol (3-month) 3140k
Avg vol (10-day) 3140k
Shares outstanding 526.37M
Implied shares outstanding 6N/A
Float 839.38M
% held by insiders 118.29%
% held by institutions 15.40%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-335.49%

Management effectiveness

Return on assets (ttm)-125.84%
Return on equity (ttm)-809.52%

Income statement

Revenue (ttm)1.38M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)-53.20%
Gross profit (ttm)N/A
EBITDA -10.68M
Net income avi to common (ttm)-10.92M
Diluted EPS (ttm)-0.5260
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.63M
Total cash per share (mrq)0.02
Total debt (mrq)35.19k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.71
Book value per share (mrq)-0.01

Cash flow statement

Operating cash flow (ttm)-7.83M
Levered free cash flow (ttm)-3.32M